How Early-Life Gut Microbiota Alteration Sets Trajectories for Health and Inflammatory Bowel Disease?

Guo, Feilong; Cai, Demin; Li, Yanwei; Gu, Haotian; Qu, Huan; Zong, Qiufang; Bao, Wenbin; Chen, Aoxue und Liu, Hao-Yu (6. August 2021): How Early-Life Gut Microbiota Alteration Sets Trajectories for Health and Inflammatory Bowel Disease? In: Frontiers in Nutrition, Bd. 8, 690073

Abstract

Inflammatory bowel disease (IBD) is a recurrent chronic inflammatory condition of the intestine without any efficient therapeutic regimens. Gut microbiota, which plays an instrumental role in the development and maturation of the immune system, has been implicated in the pathogenesis of IBD. Emerging evidence has established that early-life events particularly maternal influences and antibiotic treatment are strongly correlated with the health or susceptibility to disease of an individual in later life. Thus, it is proposed that there is a critical period in infancy, during which the environmental exposures bestow a long-term pathophysiological imprint. This notion sheds new light on the development of novel approaches for the treatment, i.e., early interventions, more precisely, the prevention of many uncurable chronic inflammatory diseases like IBD. In this review, we have integrated current evidence to describe the feasibility of the “able-to-be-regulated microbiota,” summarized the underlying mechanisms of the “microbiota-driven immune system education,” explored the optimal intervention time window, and discussed the potential of designing early-probiotic treatment as a new prevention strategy for IBD.

• Dokumententyp: Zeitschriftenartikel
• Keywords: Early-life intervention; gut microbiota; probiotics; weaning; inflammatory bowel disease
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 2296-861X
• Sprache: Englisch